Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Recruiting · NCT06452316 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency | corneal disorder, eye disorder, limbal stem cell deficiency | Recruiting | Phase 1 | 2026-08-13 | NCT06452316 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Claris Biotherapeutics, Inc. | 3 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Francis Price Jr, MD | Indianapolis | United States | 2 |
| Legacy Devers Eye Institute | Portland | United States | 4 |
| Loma Linda University Eye Institute | Loma Linda | United States | 5 |
| Midwest Cornea Associates, LLC | Carmel | United States | 2 |
| Minnesota Eye Consultants | Minnetonka | United States | 4 |
| Stuart A. Terry, MD PA | San Antonio | United States | 2 |